← Back

Wire · opportunities

Heartvue.ai and Innolitics Achieve FDA 510(k) Clearance for Heartvue.Proton, an AI ...

Published

3 September 2026

Topic

opportunities

Sectors

Medtech

Geography

United States

Source

Read at streetinsider.com

Verified

Fusion42 · 4 September 2026 · Fusion42 review

Heartvue.ai and Innolitics have received FDA 510(k) clearance for Heartvue.Proton, an AI-powered cardiac MRI analysis platform that automates key cardiac measurements and integrates with hospital systems. The clearance includes a Predetermined Change Control Plan (PCCP), allowing model updates without new FDA submissions.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 2 Sep 2026 and 3 Sep 2026.

◆ The Wire takeaway

The FDA's PCCP clearance now lets you update your AI clinical tools faster by skipping repeat submissions, giving you a sharper edge to keep medical models current and accelerate hospital adoption.

Coverage

2 sources · first reported 2 Sep 2026 · latest 3 Sep 2026

Related on Wire

Topics

Medtechfda-clearancecardiac-mriai-medical-imagingpredetermined-change-controlheartvue